CARE-MS II Eligibility Criteria

Key Inclusion Criteria

Patient Characteristics and MS History

  • Between the ages of 18-55 years
  • Diagnosis of MS and MRI scan demonstrating white matter lesions attributable to MS
  • Onset of MS symptoms within 10 years
  • EDSS score 0.0 to 5.0
  • ≥2 MS attacks within 24 months, with ≥1 attack within 12 months
  • ≥1 MS attack (relapse) during treatment with a beta interferon therapy or glatiramer acetate after having been on that therapy for at least 6 months within 10 years
  • Neurologically stable for the 30 days prior to the date the Informed Consent Form is signed